CMT focuses on the development and commercialization of regenerative therapies derived from novel processed human platelets.
Business Model:
Revenue: $0
Employees: 11-50
Address: 1055 Brookhaven Walk NE
City: Atlanta
State: GA
Zip: 30319
Country: US
Cambium Medical Technologies, founded by four blood industry luminaries out of Emory University, Atlanta, Georgia (USA)--is focused on the development and commercialization of regenerative therapies derived from novel processed human platelets. Cambium is developing Elate Ocular a standardized, commercialized platelet derived biologic eye drop for dry eye syndrome (keratoconjunctivis sicca) as its first FDA approved therapy. Elate Ocular is an investigational drug and is not yet approved for sale in or outside the United States.
Contact Phone:
+16788603725
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2017 | Series A | $5M | 5/2014 | Grant | 1 | $60k |
Georgia Research Alliance Georgia Research Alliance |
4/2012 | Grant | 1 | $25k |
Georgia Research Alliance Georgia Research Alliance |
10/2011 | Grant | 1 | $25k |
Georgia Research Alliance Georgia Research Alliance |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|